Here are four quick facts:
1. Eleven analysts agree with this consensus.
2. The higher estimate for the short term price target is $74 while the lower estimate is $64.
3. The 52-week high of the share price is $63.89 and the 52-week low is $48.73.
4. The company has a market cap of $4.3 billion.
More articles on anesthesia:
Dr. Brooke Vanderby joins Illinois Bone & Joint Institute: 4 quick facts
Somnia Anesthesia names Diana Allen VP of patient revenue — 5 quick facts
U.S. Anesthesia Partners, Medical Anesthesia and Pain Management Consultants merge: 5 key notes
